Company profile: Entegrion
1.1 - Company Overview
Company description
- Provider of innovative life sciences solutions.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Entegrion
GlycoDesign
HQ: Canada
Website
- Description: Provider of biopharmaceutical research and development, discovering and developing proprietary drugs for the treatment or prevention of cardiovascular and chronic inflammatory diseases and cancer. Focus includes anti-thrombotic candidates GH9001 and ATH and the development of glycotherapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GlycoDesign company profile →
Arteriocyte
HQ: United States
Website
- Description: Provider of cell- and tissue-based medical devices to improve surgical outcomes, including the Magellan Autologous Concentration System for extracting and concentrating platelets and growth factors, Precise for tailored platelet-rich plasma, SPARC integrative bone matrix, Fibrant cortical allografts, Influx demineralized bone matrix, and ProteiOS for spinal fusion.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arteriocyte company profile →
Akura Medical
HQ: United States
Website
- Description: Provider of a next-generation mechanical thrombectomy platform—a low-profile system for efficient removal of mixed-morphology clots in venous thromboembolism (VTE) without crossing the clot, featuring integrated aspiration and maceration technology and real-time hemodynamic data monitoring to simplify thrombectomy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Akura Medical company profile →
Drew Scientific
HQ: United States
Website
- Description: Provider of analytical instruments and reagents worldwide, including cell counters for clinical hematology, cell counters for veterinary hematology and research, hemoglobin analyzers for diabetes (HbA1c), and related reagents and controls.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Drew Scientific company profile →
ExThera Medical
HQ: United States
Website
- Description: Provider of hemoperfusion and extracorporeal blood filtration devices, including Seraph 100 for treating severe COVID-19 by removing pathogens from the bloodstream and ONCOBind for adsorbing circulating tumor cells from plasma in metastatic cancer patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ExThera Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Entegrion
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Entegrion
2.2 - Growth funds investing in similar companies to Entegrion
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Entegrion
4.2 - Public trading comparable groups for Entegrion
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →